Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Cash Flows From Operating Activities | |
| Net Income | -45,934 |
| Depreciation Amortization | 1,547 |
| Accounts payable and accrued liabilities | 2,041 |
| Other Working Capital | 7,377 |
| Other Operating Activity | 1,174 |
| Operating Cash Flow | $-33,795 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -42,217 |
| PPE Investments | -1,594 |
| Investing Cash Flow | $-43,811 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -153 |
| Common Stock Issued | 83,303 |
| Other Financing Activity | 1,130 |
| Financing Cash Flow | $84,280 |
| Beginning Cash Position | 36,062 |
| End Cash Position | 42,736 |
| Net Cash Flow | $6,674 |
| Free Cash Flow | |
| Operating Cash Flow | -33,795 |
| Capital Expenditure | -1,594 |
| Free Cash Flow | -35,389 |